BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8

• 

  Weight loss

  ADA: Lilly’s weight loss mastery shows benefits in menopause, sleep apnea, more

  Eli Lilly sauntered into the American Diabetes Association meeting with a commanding lead in the metabolic space and put down more evidence for its pipeline, including new pill Foundayo and next-gen asset retatrutide, in new indications.

  June 7, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

  June 7, 2026

   · 

  5 min read
• Press Releases

  Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

  June 7, 2026

   · 

  6 min read
• Press Releases

  Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™

  June 7, 2026

   · 

  3 min read
• Press Releases

  Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

  June 7, 2026

   · 

  9 min read
• Press Releases

  Neuronoff Implants First Patient in DOD-Funded Trial of Injectrode® for Neurogenic Bladder in Spinal Cord Injury

  June 7, 2026

   · 

  6 min read
• Press Releases

  ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network

  June 7, 2026

   · 

  5 min read
• Press Releases

  Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

  June 7, 2026

   · 

  7 min read
• Press Releases

  Memo Therapeutics AG Presents Further Analyses of the Phase II Trial Results of Potravitug for the Treatment of BKPyV Infection in Kidney Transplant Recipients in an Oral Presentation at the 63rd European Renal Association Congress

  June 7, 2026

   · 

  4 min read
• Press Releases

  Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

  June 7, 2026

   · 

  12 min read